Rv1010 Dimethyladenosine transferase (EC 2.1.1.-)

Summary

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv1010 ksgA Dimethyladenosine transferase (EC 2.1.1.-) CDS 1129152 1130105 + 954 317 FALSE

Rv1010 (Dimethyladenosine transferase (EC 2.1.1.-)) is predicted to be co-regulated in modules bicluster_0145 with residual 0.56 and bicluster_0493 with residual 0.66.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 0.00 and 0.16 for bicluster_0145 and 0.02 and 25.00 for bicluster_0493 respectively.

These modules are enriched for following go terms: riboflavin metabolic process, riboflavin biosynthetic process, flavin-containing compound metabolic pro..., flavin-containing compound biosynthetic ... .

This gene is found to be for growth on cholesterol.

Mutant available?: Yes

Last update: 10/16/2017 - 11:08
BEI Mutant Available BEI Mutant ID BEI MT Number BEI Target ID Order from BEI
Yes NR-15078 MT1039 1321
Product (LegacyBRC) Product (RefSeq)
Dimethyladenosine transferase dimethyladenosine transferase
Operon # Operon
677 -
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics

PATRIC

Not assigned Not assigned
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

not assigned to any KEGG Pathway.
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
15608150 NP_215526.1 Run
GO:0008649

rRNA methyltransferase activity

rRNA methyltransferase activity

Details: 
Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to a nucleoside residue in an rRNA molecule.
GO Category: 
molecular_function
1
Total items in this category:  
GO:0000154

rRNA modification

rRNA modification

Details: 
The covalent alteration of one or more nucleotides within an rRNA molecule to produce an rRNA molecule with a sequence that differs from that coded genetically.
GO Category: 
biological_process
1
Total items in this category:  
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
0.230000 3.28

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: